Serina Therapeutics (SER) Tax Provisions (2019)
Serina Therapeutics (SER) posted Tax Provisions of $18000.0 for Q4 2019, down 66.67% sequentially from $54000.0 in Q3 2019.
Serina Therapeutics (SER) Tax Provisions (2019) Analysis & Trends
Serina Therapeutics has reported Tax Provisions for 1 years, with the latest figure at $18000.0 in Q4 2019.
- Quarterly Tax Provisions changed N/A year-over-year to $18000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $148000.0 (changed N/A YoY) and the FY2025 annual result came in at $18000.0, changed N/A from the prior year.
- Tax Provisions retreated to $18000.0 in Q4 2019 per SER's latest filing, from $54000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $73000.0 in Q1 2019 and troughed at $3000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Serina Therapeutics | 43.17 Mn | 20.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 54,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 73,000.00 |